News
We are working at the cutting edge of healthcare analytics. Stay informed here.
Recent News
Selected startups will advance technology-driven improvements in heart and brain health
June 2024
The American Heart Association, through its Center for Health Technology and Innovation (the Center), has selected five companies to participate in the American Heart Association Heart and Brain Health Accelerator. The AHA Heart and Brain Health Accelerator is a track of the larger MedTech Innovator (MTI) Accelerator Program where more than 60 medical technology and digital health companies will have shared access to robust ecosystem of Association volunteer experts, corporate executives, investors, providers, payors, the Food and Drug Administration, National Institutes of Health, Department of Defense, and other stakeholders from June to October. Through the Accelerator, the Association – a global force for healthier lives for all – aims to accelerate innovation with the potential to enhance patient outcomes, lower costs and reduce barriers to care.
Read moreAccurKardia has been selected for the prestigious MedTech Innovator 2024 Cohort and the Heart and Brain Health Accelerator track in collaboration with the American Heart Association’s Center for Health Technology and Innovation
May 2024
This year, approximately 1,300 companies applied to Medtech Innovator, and only 65 were selected (just 5%), including just five into the Heart and Brain Health Accelerator track. MedTech Innovator is the world’s largest accelerator of medical technology companies. This distinction provides AccurKardia with additional mentorship and opportunities to participate in industry events, enhancing its visibility and impact in the healthcare sector.
Read moreAccurKardia Delivers Its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions
November 2023
AccurKardia announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership paves the way for AccurKardia to integrate its FDA-Cleared ECG Interpretation Software Platform, AccurECG™ Analysis System, into Lucem Health Reveal, a family of solutions that identify patients who may be at higher risk of severe or chronic diseases.
Read moreAccurKardia’s AccurECG™ Analysis System Receives FDA 510(k) Clearance
July 2023
AccurKardia announced today that its flagship product, the AccurECG™ Analysis System (“AccurECG” or the “System”), has been granted FDA 510(k) clearance. AccurECG™ is a cloud-based, device-agnostic and fully automated electrocardiogram (ECG) interpretation software platform.
Read moreAccurKardia Announces Final Closing of $2.7 Million Series Seed Round
June 2023
AccurKardia announced our final closing and completion of our $2.7 million Series Seed round. This funding milestone marks a significant step towards AccurKardia’s goal of improving patients’ outcomes and saving millions of lives regardless of geography.
Read moreAccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch
October 2022
AccurKardia announced today it will collaborate with Mawi, to integrate its proprietary ECG analytics into Mawi’s new cardiac monitoring watch. This collaboration highlights AccurKardia’s commitment to enabling world-class cardiac-care through remote patient monitoring solutions.
Read moreAccurKardia's ‘AccurBeat' Found to be Promising Alternative in QT/QTc Remote Monitoring According to Study by HITLAB and SUNY Downstate
October 2022
AccurKardia’s AccurBeat has been found to be a promising new alternative for QT/QTc remote monitoring according to a new study published on JMIR Publications and conducted by HITLAB and SUNY Downstate College of Medicine.
Read moreAccurKardia joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
August 2022
The AccurKardia team is excited to join the Innovators’ Network. We are eager to engage with the other network members and the Center, as we pursue our goal of delivering ECG analytics solutions that improve patient outcomes.
Read moreTelehealth 2.0: Remote Patient Monitoring Tools to Give Shot in the Arm to Telehealth
April 2022
Our Co-Founder and CEO, Juan C. Jimenez recently authored an article published by Nasdaq on Telehealth 2.0, discussing how remote patient monitoring tools can give a ‘shot in the arm’ to the virtual care revolution.
Read moreHealth Tech: Juan Jimenez On How AccurKardia’s Technology Can Make An Important Impact On Our Overall Wellness
March 2022
In this interview AccurKardia's CEO describes how the Company is improving patients' outcomes and saving lives.
Read more"AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes"
January 2022
AccurKardia today announced a collaboration with MDF Instruments to develop ECG (electrocardiogram) solutions for the next generation of stethoscopes. This collaboration brings together AccurKardia’s cutting edge innovation in device-agnostic, automated ECG analytics with clinical-grade accuracy and MDF Instruments’ more than 40 years of experience designing, manufacturing, and distributing premium diagnostic instruments.
Read more"BestStartup.us" recognizes AccurKardia in its top picks for the best New York City based Health Diagnostics companies
August 2021
This article showcases 62 top picks for the best New York City based Health Diagnostics companies. AccurKardia was identified as a cutting edge startup that is taking a variety of approaches to innovating the Health Diagnostics industry.
Read more"Life Science Intelligence" includes AccurKardia in LSI's Medtech Startup Tracker
July 2021
Life Science Intelligence's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.The AccurKardia platform will be device agnostic and will support automated detection and diagnosis for ambulatory, in-patient telemetry, and consumer ECG devices. As the prevalence of arrhythmia increases in proportion with the growing elderly population, easy-to-use solutions for the detection and diagnostic will become an essential tool to slow the progression of this chronic condition.
Read moreFeatured on "The Startup Pill's" 101 top picks for the best Health Diagnostics startups in 2021
January 2021
This article showcases The Startup Pill’s top picks for the best Health Diagnostics startups. Accurkardia was included as one of the 101 companies or start up for its contribution to the healthcare space around the world. AccurKardia was mentioned as an exceptional startups well worth a follow.
Read more